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Abstract  41 
Background: Diabetic peripheral neuropathy is an important cause of foot ulceration and limb loss. 42 
This systematic review and meta-analysis investigated the effect of diabetic peripheral neuropathy on 43 
gait, dynamic electromyography and dynamic plantar pressures. 44 
 45 
Methods: Electronic databases were searched systematically for articles reporting the effect of 46 
diabetic peripheral neuropathy on gait, dynamic electromyography and plantar pressures.  Searches 47 
were restricted to articles published between January 2000 and April 2012. Outcome measures 48 
assessed included spatiotemporal parameters, lower limb kinematics, kinetics, muscle activation and 49 
plantar pressure. Meta-analyses were carried out on all outcome measures reported by ≥ 3 studies. 50 
 51 
Findings: Sixteen studies were included consisting of 382 neuropathy participants, 216 diabetes 52 
controls without neuropathy and 207 healthy controls. Meta-analysis was performed on 11 gait 53 
variables. A high level of heterogeneity was noted between studies. Meta-analysis results suggested a 54 
longer stance time and moderately higher plantar pressures in diabetic peripheral neuropathy patients 55 
at the rearfoot, midfoot and forefoot compared to controls. Systematic review of studies suggested 56 
potential differences in the biomechanical characteristics (kinematics, kinetics, EMG) of diabetic 57 
neuropathy patients. However these findings were inconsistent and limited by small sample sizes.  58 
 59 
Interpretation: Current evidence suggests that patients with diabetic peripheral neuropathy have 60 
elevated plantar pressures and occupy a longer duration of time in the stance-phase during gait. Firm 61 
conclusions are hampered by the heterogeneity and small sample sizes of available studies.  62 
 63 
Key Words – Diabetic Peripheral Neuropathy, Biomechanics, Gait, Diabetes Complications, Type 2 64 
Diabetes, Type 1 Diabetes, Plantar Pressure, Electromyography, Movement analysis, Diabetic Foot, 65 
Diabetes Mellitus, Meta-analysis, Systematic Review  66 
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1. Introduction 68 
One of the many consequences of diabetes is the onset of diabetic peripheral neuropathy (DPN) 69 
(Shenoy, 2012). The prevalence of DPN ranges from 13 to 68% in diabetes populations (van Dieren et 70 
al., 2010). Peripheral neuropathy affects the sensory, motor, and autonomic components of the 71 
nervous system, manifesting as a loss of protective sensation, intrinsic foot muscle dysfunction and 72 
anhydrosis of the foot (Shenoy, 2012). These manifestations often lead to bony deformities and high 73 
plantar pressure areas which result in skin breakdown and ulceration (Boulton et al., 2005). It is 74 
believed that the majority of diabetic foot ulcers develop as a result of the repetitive action of 75 
mechanical stress (pressure) during gait, in the presence of peripheral neuropathy or loss of protective 76 
sensation (Armstrong et al., 2004). Lower-limb amputations in people with diabetes are typically 77 
preceded by foot ulceration, suggesting that better understanding of the mechanisms of ulcer 78 
development are of vital importance (Singh et al., 2005). This includes better understanding of the 79 
biomechanical components (Formosa et al., 2013). 80 
 81 
It has been postulated that DPN-related changes in the lower limbs may lead to functional gait 82 
variations; predominantly related to reduced range of movement of joints, reduced active muscle 83 
power and changes in gait mechanics (Andersen, 2012). The biomechanical changes resulting from 84 
DPN may translate to increased plantar pressures in the foot, which contributes to the pathogenesis 85 
and development of foot ulcers, especially in the forefoot (Van Deursen, 2004). In particular, the first 86 
metatarsophalangeal joint has been implicated as a site of biomechanical dysfunction leading to 87 
elevated plantar pressures during gait, promoting ulceration at this site (Turner et al., 2007).  88 
Therefore, we hypothesised that reductions in spatiotemporal parameters, increases in kinetics 89 
(specifically the vertical ground reaction force and joint moments), and reductions in kinematics of 90 
the lower limb (evident as restrictions in the sagittal plane) and altered dynamic electromyography 91 
(EMG) findings in those with DPN may manifest from or contribute towards altered plantar pressure 92 
loading in this population (Cavanagh et al., 2000). Therefore, this systematic review and meta-93 
analysis aimed to assess the effect of DPN on gait (spatiotemporal parameters, joint angular kinematic 94 
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and kinetics), dynamic EMG (muscle activation and deactivation patterns) and dynamic barefoot 95 
plantar pressures (plantar foot pressures during gait). We sought case-control studies comparing 96 
patients with DPN to those with diabetes mellitus without neuropathy (Diabetes Mellitus Controls) 97 
(DMC) or healthy controls (HC). 98 
 99 
2. Methods 100 
2.1 Literature search strategy 101 
Electronic databases (Ovid, CINAHL, PubMed, Scopus and Google Scholar) were searched 102 
systematically by the first author for articles published between January 2000 to April 2012, reporting 103 
studies on DPN in the three biomechanical areas of gait, dynamic EMG and plantar pressure. The 104 
initial search was conducted in April 2012. An additional search was conducted in January 2013 to 105 
ensure any further articles were also assessed for inclusion prior to publication. No new articles were 106 
found. Search results were restricted to articles published between January 2000 and January 2013. 107 
Publications prior to the twenty first century were not included to restrict the focus of the review to 108 
the most recent findings from studies which assessed gait using current technology, which is more 109 
reliable and comprehensive. This is especially true in relation to three dimensional joint angular 110 
kinematic analysis which was introduced at around this time (Sutherland, 2001, Sutherland, 2002, 111 
Sutherland, 2005). The following keywords and MeSH headings were used: 112 
#1 Gait AND diabetes 113 
#2 electromyograph* AND diabetes 114 
#3 EMG AND diabetes 115 
#4 biomechanic* AND diabetes 116 
#5 kinematic AND diabetes 117 
#6 plantar pressure AND diabetes 118 
#7 (diabetes MeSH) AND 1# AND 2# AND 3# AND 4# AND # 5 119 
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#8 (diabetic foot MeSH) AND 1# AND 2# AND 3# AND 4# AND # 5 120 
#9 (diabetic neuropathy MeSH) AND 1# AND 2# AND 3# AND 4# AND # 5 121 
 122 
2.2 Selection of studies 123 
The titles and abstracts retrieved from the initial database search were screened by the first author 124 
utilising the question ‘Did the study investigate one of the three biomechanical areas of interest?’ The 125 
full text was obtained for articles that remained relevant after the initial screening.  One of the authors 126 
then reviewed the full text for the final decision on inclusion utilising the entry criteria. All articles 127 
meeting these initial criteria had their full-texts retrieved and were then further evaluated by two 128 
authors (MF and RC) using the inclusion and exclusion criteria below. All studies meeting the 129 
exclusion criteria were removed from the review. 130 
The inclusion criteria were: 131 
1. Studies published between 2000 and 2012; 132 
2. Studies in English language; 133 
3. Studies reporting findings in clearly identified DPN groups in comparison to a DMC and/or a 134 
HC group using eligible inclusion and/or screening criteria; 135 
4. Studies investigating barefoot walking. Barefoot investigations were chosen over shod as this 136 
was thought to provide insight into biomechanical parameters without the influence of shoes; 137 
5. Studies in adult populations  (≥ 18 years old); 138 
6. Study reported findings for at least 1 outcome measure of interest in the review. 139 
 140 
Exclusion criteria were: 141 
1. Any study investigating participants gait, EMG or plantar pressure while wearing shoes, 142 
inserts or orthotic devices; 143 
2. Any study which included current or past diabetes foot ulcer participants as a part of their 144 
DPN or DMC groups; 145 
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3. Studies that investigated movement on a treadmill; 146 
4. Studies where reported outcome measures were not comparable with at least one outcome 147 
measure of interest and could not be converted; 148 
5. Studies where authors were unable to provide datasets or outcome variables that were 149 
compatible for comparison (mean and standard deviation, SD), in place of missing data. 150 
 151 
2.3 Outcome measures 152 
Studies were included in the review if they reported at least one of the following outcome measures: 153 
1. Spatiotemporal- walking speed (m/s) with or without stride length (m); 154 
2. Kinetics- reported findings on net moments of force (flexion and extension) for at least one 155 
lower limb joint (ankle, knee or hip) and/or reported ground reaction force at initial contact 156 
and/or toe-off as separate values; 157 
3. Kinematics- reported range of motion (ROM) findings for at least one lower limb joint (ankle, 158 
knee or hip) in both flexion and extension directions; 159 
4. EMG- activation and deactivation durations of any lower limb muscle during walking in % 160 
stance or % gait cycle; 161 
5. Plantar pressure- reported on at least one site at the rearfoot or midfoot or forefoot or in any 162 
other plantar location in either peak plantar pressure (MPP) or pressure time integral (PTI) or 163 
both. 164 
 165 
2.4 Assessment of methodological quality of studies 166 
Two assessors (MF and PL) independently evaluated the quality of the studies utilising a modified 167 
version of the quality assessment tool by Downs and Black (Downs and Black, 1998). The criteria 168 
within the tool which were not applicable to the studies included in this review were omitted from the 169 
analysis (see Table 1). The total quality scores were reported as an average score between the two 170 
assessors. As a simplified version of the quality assessment instrument tool by Downs and Black 171 
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(Downs and Black, 1998) was utilised, the original scoring system for the tool was scaled according 172 
to a total score of 18. Therefore, a score of ≤ 7 was considered low quality, 8-11 as fair quality and 173 
>11 as good quality. 174 
 175 
2.5 Data extraction and reporting 176 
Data extraction was performed by the first author with assistance from a statistician (PB) for data 177 
analysis. Data were entered into tables for ease of comparison and grouping of variables. Only studies 178 
that reported the outcome measures of interest were used in the statistical analysis that followed. 179 
Descriptive characteristics of participants (age, gender, body mass index, BMI), entry criteria for 180 
diagnosis of DPN, site of participant recruitment, exclusion criteria used by study and diabetes 181 
duration of groups were recorded. Where data were missing or unreported, authors from the studies 182 
were contacted  in an attempt to obtain or clarify results. Where authors did not reply, the studies were 183 
excluded from the review. The MOOSE guidelines for reporting meta-analysis of observational 184 
studies were utilised in the synthesis of this review (Stroup et al., 2000). 185 
 186 
2.6 Statistical analysis 187 
Where possible, data were transformed into standardised units of measure for comparison and for 188 
statistical analysis. Means (weighted by sample size of the study) were calculated for the reported 189 
demographic variables. Meta-analysis was carried out on individual outcome measures when more 190 
than three studies reported on the particular individual outcome measure. Difference in mean values 191 
divided by pooled SD was used to compute effect size, utilising Cohen’s d (Cohen, 1988). 192 
Heterogeneity of studies was calculated using the Q-statistic and I
2 
statistic. Results were reported as 193 
standardised mean differences with 95% confidence intervals and p values. In addition to this, the 194 
classic fail safe N was also computed, as this gives an estimation of studies needed to be published 195 
with a null effect to renounce the effects from the meta-analysis (Persaud, 1996). For purposes of 196 
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analysis, a Cohen’s d score of zero was interpreted as no difference in effect; a result of 0 to 0.2 was 197 
interpreted as a small effect; 0.2-0.5 as a medium effect; and ≥ 0.8 as a large effect (McGough and 198 
Faraone, 2009). All statistical analyses were carried out by a statistician (PB). 199 
 200 
3. Results 201 
3.1 Search yield 202 
Figure 1 outlines the process and results of each step of the literature search. Overall, 1813 unique 203 
records were originally identified. However, 1800 articles were excluded for a variety of reasons, such 204 
as inappropriate study design, use of inappropriate comparison groups, unsuitable methods used in 205 
data capture, lack of neuropathy classification, missing data, irrelevant data or because data were 206 
unable to be acquired from authors. Thus 13 articles remained eligible for inclusion. Three extra 207 
articles were located by hand searching reference lists of included articles. Therefore, 16 articles were 208 
included in the review. Several studies reported on more than one focus area. Gait findings 209 
(spatiotemporal parameters, kinematics and kinetics) were reported in ten studies. Dynamic EMG 210 
results were reported in three studies and barefoot dynamic plantar pressure in seven studies. Table 2 211 
displays a summary of the characteristics of participants in included studies. 212 
 213 
3.2 Study quality 214 
Although there were minor differences in ratings between quality assessors for studies, the overall 215 
agreement between quality assessors was good. There were no studies which had a score ≤ 7 and 216 
therefore seven studies were of fair quality (8-11) and nine studies were of good quality (>11) 217 
according to the quality assessment instrument (Downs and Black, 1998). The main difference 218 
between the studies that achieved a good quality compared to a fair quality was the reporting of actual 219 
probability values (i.e. P =0.004) rather than approximate values (i.e. P <0.05) along with a more 220 
comprehensive list of confounding variables. Additionally, the ‘good quality’ studies described the 221 
demographic and recruitment sites of the participants in detail and reported the populations of 222 
recruitment for groups as being the same or different. This information is important for assessing the 223 
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external and internal validity of studies. The majority of ‘good quality’ studies also used a means of 224 
adjustment for confounding with or without using multiple regression analysis. 225 
 226 
None of the studies reported sample size calculations. All except two studies had clear aims (Sawacha 227 
et al., 2012a, Sawacha et al., 2012b). All studies differed in reporting of confounding variables, 228 
especially pertaining to biomechanical outcomes. Important confounders of relevance included 229 
diabetes duration, severity of DPN, presence of foot deformity, BMI, gender and presence of 230 
claudication pain or presence of peripheral arterial disease (PAD) affecting gait. One study (Melai et 231 
al., 2011) did not report any major confounders. One study did not provide random estimates of 232 
variability in their manuscript, however this was found in the supplementary material (Sawacha et al., 233 
2012a). It was difficult to ascertain whether or not the recruited samples were representative of the 234 
source population in most studies, however some studies stated the recruitment strategy clearly. Only 235 
one study commented on the number of participants who accepted and rejected invitation for the study 236 
as part of the external validity assessment (Savelberg et al., 2009). Lastly, only one study reported on 237 
time frames for recruitment, as it was a part of a larger study (Caselli et al., 2002). For other studies 238 
this could not be determined. 239 
 240 
3.3 Participant characteristics 241 
There were 382 DPN participants (cases) in total from the 16 included studies. The mean group size 242 
was 25.5 and ranged from 8 to 76 participants. The age range of participants in the DPN group was 54 243 
to 69 years with a weighted mean age of 61 years. The majority (55%) of subjects were males with a 244 
BMI of 24 to 30 kg/m
2 
(weighted mean 28 kg/m
2
). The weighted mean diabetes duration in the DPN 245 
group was 15.2 (range 12 to27) years. 246 
 247 
Studies utilised a variety of participant recruitment sources including community outpatient settings 248 
(8/16), hospital settings (3/16), volunteers (2/16), previous studies (1/16) or unspecified (2/16). 249 
Thirteen studies utilised HC groups for comparison which were recruited on a voluntary basis from 250 
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the community or through hospital staff. Nine studies (9/16) used DMC groups usually recruited from 251 
the same setting as DPN patients. A summary of the recruitment methods can be found in Table 3. 252 
 253 
Table 3 presents screening criteria for the diagnosis of DPN and population source of samples used in 254 
each study as well as additional exclusion criteria used. A range of methods were used in the 255 
diagnosis of DPN in different studies. Eleven studies utilised a validated screening tool to assess 256 
sensory neuropathy. The most commonly used was the Michigan Neuropathy Screening Instrument 257 
(MNSI). A few studies used only clinical assessment (4/16) and one study utilised nerve conduction 258 
testing to assess both motor and sensory neuropathy (Yavuzer et al., 2006). All studies disqualified 259 
patients with previous or current diabetes foot ulcers from inclusion in the DPN group and excluded 260 
those with additional orthopaedic and neurological conditions, rheumatological conditions and 261 
disabilities which produce walking constraints. Two studies excluded participants with PAD, assessed 262 
on clinical examination or with ankle brachial pressure index (ABPI) values <0.85 (Uccioli et al., 263 
2001, Guldemond et al., 2008). Two studies did not specify exclusion criteria (Sawacha et al., 2009a, 264 
Caselli et al., 2002). 265 
 266 
The DMC group comprised of 216 participants with a mean sample size of 24. The age of patients 267 
was 50 to 64 years with a weighted mean age of 57 years. The BMI of this group ranged from 25 to 268 
30 kg/m
2 
with a weighted mean of 28 kg/m
2
. The majority of participants were male (50%) and the 269 
total diabetes duration was lower than for the DPN group; ranging from 8 to 23 years and with a 270 
weighted mean of 14 years. The HC group comprised of 207 participants with a mean sample size of 271 
15.9. The age of participants ranged from 46 to 68 years with a weighted mean age of 58 years. The 272 
majority of HC participants were male (53%) with a BMI range between 24 and 29 kg/m
2 
and with a 273 
weighted mean BMI of 25 kg/m
2
. The findings from the studies are reported in their respective 274 
sections below and in Tables 4-8. Meta-analysis was carried out for 11 separate gait variables (Table 275 
9). Forest-plots of all significant meta-analyses can be found as additional figures (Figures 2-9). 276 
 277 
 278 
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3.5 Spatiotemporal parameters 279 
There was a marked difference in the walking speeds reported amongst the three groups in different 280 
studies (Table 4). Three studies reported that DPN participants walked slower than HC subjects 281 
(Gomeset al., 2011, Sawacha et al., 2009b, Savelberg et al., 2010) and two studies reported slower 282 
walking speeds in the DPN group compared to the DMC patients (Savelberg et al., 2010, Sawacha et 283 
al., 2012b). However, two studies reported DPN participants walked faster than both HC and DMC 284 
groups (Savelberg et al., 2009a, Yavuzer et al., 2006). 285 
 286 
Meta-analysis results combining data from studies for walking speed (DPN group vs. DMC group and 287 
DPN group vs. HC group) and stride length (DPN group vs. DMC group) between the three groups 288 
demonstrated no significant difference in  walking speed and stride length. There was also a high level 289 
of heterogenity present. Two studies reported stride length findings for the DPN group compared to 290 
the HC group and both studies reported lower values in DPN patients (Sawacha et al., 2009, 291 
Savelberg et al., 2010). 292 
 293 
One study reported stance phase duration as a percentage of the gait cycle (Sawacha et al., 2012b).  294 
These findings were consistent with the above findings suggesting DPN patients had longer 295 
percentage duration in the stance phase of gait (Table 4). Meta-analysis combining data from three 296 
studies (DPN n=54, DMC n=51) suggested that patients with DPN had a longer stance time at a 297 
moderate effect level (standardised mean difference 0.54, 95% CI 0.15-0.93; P=0.006). The 298 
heterogeneity between studies was minimal I
2
= 0. 299 
 300 
3.6 Kinematics 301 
Only one study reported on kinematics at the hip, knee and ankle in both extension and flexion 302 
directions (Table 5) (Gomes et al., 2011). While DPN participants exhibited greater hip flexion 303 
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(degrees) when compared to HC subjects, the DPN participants also demonstrated reduced hip 304 
extension, knee flexion and knee extension when compared to the HC group. Both maximum ankle 305 
plantar flexion and ankle dorsiflexion were reduced in DPN participants when compared to the HC 306 
group. Meta-analysis was not possible for these results. 307 
 308 
3.7 Kinetics 309 
Five studies reported kinetic variables (Yavuzer et al., 2006a, Savelberg et al., 2009b, Sawacha et al., 310 
2012a, Uccioli et al., 2001, Saura et al., 2010) (Tables 5 and 6).  Two studies reported on the force 311 
generation components at the ankle, knee and hip (Savelberg et al., 2009c, Yavuzer et al., 2006) 312 
(Table 6). According to one study, both the braking and propelling forces were reduced in the DPN 313 
group compared to both DMC and HC groups (Savelberg et al., 2009b).  Both the first maximum 314 
support moment and mid stance minimal support moment were elevated in DPN participants 315 
compared to the DMC and HC groups; however the second maximum support moment was slightly 316 
higher in the DMC group when compared to DPN patients (Savelberg et al., 2009b). 317 
 318 
The results for maximum ankle plantar flexion moment were inconsistent. One study reported a 319 
higher value in DPN patients compared to controls (Savelberg et al., 2009b); while another study 320 
reported a lower value in DPN patients when compared to HC subjects (Yavuzer et al., 2006). Results 321 
for knee extension moments were also inconsistent. One study reported reduced extension moments in 322 
DPN patients (Savelberg et al., 2009b) and another higher extension moments in DPN patients when 323 
compared to both the DMC and HC groups (Yavuzer et al., 2006). However, both studies reported 324 
greater knee flexion moment in the DPN group compared to both the DMC and HC groups (Savelberg 325 
et al., 2009c, Yavuzer et al., 2006) (Table 6). 326 
 327 
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According to a single study, the hip extension moment was greater in the DPN group when compared 328 
to both control groups (Savelberg et al., 2009b). According to both studies, the hip flexion moment 329 
was also reduced in DPN patients compared to both controls (Savelberg et al., 2009b, Yavuzer et al., 330 
2006). 331 
 332 
Meta-analysis was only possible for the vertical GRF (first peak) at initial contact. Although reported 333 
vertical GRF were higher in DPN patients compared to both HC and DMC groups, the results from 334 
the meta-analysis were statistically insignificant with a high level of heterogenity. Meta-analysis was 335 
not possible for vertical GRF at toe-off (second peak) (Table 5). However, one study reported a higher 336 
vertical GRF value in DPN patients at toe-off  (Saura et al., 2010) and another a lower value (Yavuzer 337 
et al., 2006). 338 
 339 
3.8 Dynamic EMG 340 
Muscle activation was reported for several different lower limb muscle groups (Table 7). Two studies 341 
reported findings as % stance phase ((Akashi et al., 2008, GOMES et al., 2011) and one study as % 342 
gait cycle (Sawacha et al., 2012b). Three studies reported the duration of activity of the tibialis 343 
anterior muscle (Sawacha et al., 2012b, Akashi et al., 2008, Gomes et al., 2011). Meta-analysis 344 
suggested a non-significant longer duration of muscle activity in the tibialis anterior muscle in DPN 345 
patients when compared to the HC group. 346 
 347 
Meta-analysis was not possible for the other muscle groups due to lack of studies.  However, 348 
according to two studies, the lateral gastrocnemius muscle had reduced duration of activity in DPN 349 
patients (% stance phase) when compared to the HC group (Akashi et al., 2008, Sawacha et al., 350 
2012b). On the contrary, assessment of the vastus lateralis muscle suggested a longer duration of 351 
activation in DPN patients when compared to the HC group (Akashi et al., 2008, Gomes et al., 2011). 352 
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There were conflicting results from two studies which assessed activity of the peroneus longus muscle 353 
(Table 7). One study reported reduced duration of muscle activation in DPN patients (% stance phase) 354 
compared to the HC group; and another study reported longer duration (% gait cycle) in DPN patients 355 
compared to both HC and DMC groups. 356 
 357 
The findings from the assessment of the gluteus medius muscle, rectus femoris muscle and medial 358 
gastrocnemius muscles were from single studies and are highlighted in Table 7. Both gluteus medius 359 
and rectus femoris muscles were reported to have reduced duration of activity (Sawacha et al., 360 
2012b), whilst the medial gastrocnemius was reported to have longer duration of activity (Gomes et 361 
al., 2011) in DPN patients. 362 
 363 
3.9 Plantar Pressure (Peak Pressure and Pressure time Integral) 364 
Six studies reported plantar pressure data of interest ((Melai et al., 2011, Guldemond et al., 2008, 365 
Bacarin et al., 2009, Sacco et al., 2009, Caselli et al., 2002, Sawacha et al., 2012a) (Table 8). The 366 
majority of studies reported plantar pressure as MPP while three studies reported PTI (Melai et al., 367 
2011, Bacarin et al., 2009, Sacco et al., 2009). 368 
 369 
Meta-analysis combining data from three studies (DPN n=108, HC n= 55) suggested patients with 370 
DPN had elevated plantar pressure (both MPP and PTI) at the rearfoot at moderate effect levels (MPP 371 
standardised mean difference 0.45, 95% CI 0.09-0.82 P≤0.001, I2=7.0; and PTI standardised mean 372 
difference 0.40, 95% CI 0.05-0.75 p=0.02 I
2
=0). Both results contained minimal heterogeneity. Meta-373 
analysis results for MPP at the rearfoot were insignificant for DPN patients when compared to DMC 374 
patients (Table 9). 375 
 376 
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Meta-analysis results for the midfoot (DPN n=108, HC n= 55, combining three studies) revealed 377 
greater MPP and PTI in DPN patients (MPP standardised mean difference 0.72, 95% CI 0.37-1.08 378 
P≤0.001 I2=0; and PTI standardised mean difference 0.50, 95% CI 0.15-0.85 p=0.005 I2=7.0). There 379 
was minimal heterogeneity between studies. 380 
 381 
Meta-analysis for plantar pressure at the forefoot (DPN n=177, DMC n= 102, HC n= 55, combining 382 
three studies) demonstrated greater MPP in the forefoot of DPN patients at moderate effect levels 383 
compared to the HC group (standardised mean difference 0.55, 95% CI 0.20-0.90 p=0.002 I
2
=0) and 384 
DMC group (standardised mean difference 0.51, 95% CI 0.24-0.78 P≤0.001 I2=10.1) respectively. 385 
Furthermore, meta-analysis for PTI at the forefoot (DPN n=177, HC n= 55, combining three studies) 386 
suggested that forefoot PTI was also elevated in DPN patients at moderate effect levels (standardised 387 
mean difference 0.66, 95% CI 0.31-1.02; P≤0.001; I2=0). There was minimal heterogeneity between 388 
studies. Meta-analysis results for the hallux (MPP and PTI) comparing plantar pressure between the 389 
three groups revealed non-significant differences (Table 9). 390 
 391 
Findings from two studies suggested MPP at the plantar aspect of the first metatarsophalangeal joint 392 
was higher in the DPN group compared to the DMC group (Guldemond et al., 2008, Melai et al., 393 
2011), while results from one study suggested MPP at the plantar aspect of the first 394 
metatarsophalangeal joint was higher in DPN patients compared to the HC group (Melai et al., 2011). 395 
According to a single study, the PTI values were higher in DPN patients compared to both DMC and 396 
HC groups (Melai et al., 2011). However, according to the same study, there was a lower PTI and 397 
MPP for the DPN group in the lesser toes compared to both control groups (Melai et al., 2011) (Table 398 
7). 399 
 400 
 401 
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 402 
4. Discussion 403 
To the best of the authors’ knowledge this is the first systematic review and meta-analysis of studies 404 
investigating the gait cycle, muscle activation and plantar pressure exclusively in DPN patients 405 
compared to DMC and HC groups. The aim of this review and meta-analysis was to assess the gait 406 
dissimilarities between DPN, DMC and HC subjects in relation to spatiotemporal, kinetic, kinematic, 407 
EMG and plantar pressure variables. Our findings, within the limitations of the review, indicate gait 408 
differences in DPN patients when compared with DMC and HC subjects, likely resulting from 409 
sensory and motor neuropathy (Kovac et al., 2011, Andersen, 2012). The primary advantage of 410 
relating both HC and DMC groups to DPN patients was the ability to appreciate subtle differences 411 
within each group for comparison and contrast. However, it must be emphasised that there was a high 412 
level of heterogeneity for most variables between studies as highlighted by the Q and I
2
 statistics. This 413 
high level of heterogeneity was also evident in other systematic reviewers investigating plantar 414 
pressures in similar patient groups (Monteiro-Soares et al., 2012, Crawford et al., 2007). 415 
 416 
DPN is a significant complication of diabetes and accounts for significant morbidity and mortality 417 
(Boulton, 1998, Cook and Simonson, 2012). The primary risk factor for DPN is hyperglycaemia as it 418 
leads to increased oxidative stress, production of advanced glycation end products, increased polyol 419 
pathway flux and protein kinase C activation. All these factors are believed to contribute to micro-420 
vascular disease and nerve dysfunction (Park et al., 2004).  The end result of DPN can be catastrophic 421 
for patients, as this leads to foot ulceration and increased risk of limb amputation, significant 422 
healthcare costs, reduced quality of life and reduced mobility (Price, 2004, Boulton, 2005, Singh et 423 
al., 2005). Therefore, understanding the impact of DPN on the biomechanical aspects of human 424 
locomotion is clinically important (Formosa et al., 2013).  425 
  426 
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We hypothesised that spatiotemporal parameters would be significantly reduced in DPN patients 427 
compared to both controls. The majority of reported findings indicated that DPN patients walked 428 
slower and had reduced stride length when compared to both DMC and HC groups, however, meta-429 
analysis results were statistically insignificant. The only significant finding was that DPN patients 430 
expended a longer period of time in the stance phase compared to DMC subjects. We hypothesised 431 
that the force generation at the hip, knee and ankle would be significantly increased for both flexion 432 
and extension moments in participants with DPN. There were insufficient studies to carry out meta-433 
analysis and the two studies which reported findings demonstrated conflicting results. Regardless of 434 
the fact that one study utilised a significantly younger HC group, the differences between studies 435 
could not be solely explained by a difference in the age groups (Yavuzer et al., 2006). Irrespective of 436 
this, increased knee flexion moment in the DPN group was reported by both studies, emphasising that 437 
greater force generation may occur during knee flexion in DPN patients. This finding suggests the 438 
possibility that knee flexion might be an important compensation strategy in patients with DPN, as the 439 
motor component of DPN manifests in a stocking and glove distribution and affects the distal joints 440 
first (Tesfaye and Selvarajah, 2012). 441 
 442 
The first maximum support moment (combination of extensor moments at hip, knee and ankle) 443 
(Winter, 1980) was higher in the DPN group when compared to the DMC and HC groups (Savelberg 444 
et al., 2009). Although reported in a single study, this suggests combined forces at the hip; knee and 445 
ankle during the stance phase are greater in DPN patients compared to both control subjects 446 
(Savelberg et al., 2009). Further studies are needed to confirm this finding.  447 
 448 
Even though meta-analysis of the vertical GRF demonstrated that DPN patients had a higher initial 449 
contact force than DMC and HC subjects, the level of heterogeneity in studies was high and the meta-450 
analysis results statistically insignificant. It was anticipated that DPN patients would exhibit higher 451 
GRF due to neurological deficit and reduced proprioception but the current findings fail to support 452 
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this hypothesis. Similarly, we hypothesised that participants with DPN would exhibit reductions in 453 
joint ROM at the hip, knee and ankle during gait, as a result of motor neuropathy (Andersen, 2012). 454 
There were few studies investigating lower limb kinematics of DPN patients during locomotion to 455 
investigate this hypothesis. One study (Sawacha et al., 2012a)  reported kinematic variables of the 456 
foot which were outside the scope of this review and were not included. Therefore, current findings 457 
for joint angle kinematics were drawn from one publication investigating barefoot lower limb 458 
kinematics (Gomes et al., 2011). With the exception of hip flexion, the findings demonstrated reduced 459 
ROM in DPN patients compared to HC subjects. This finding was consistent with our hypothesis. A 460 
higher proportion of hip flexion is also another possible compensatory mechanism to increase stability 461 
in the gait strategy of DPN patients. Increased hip flexion could also be a compensatory mechanism to 462 
adjust for impaired ankle dorsiflexion in patients with DPN. We did not directly examine this 463 
possibility in the current review. Further studies are needed to clarify the cause of greater joint force 464 
in knee flexion and greater degree of hip flexion in patients that have DPN. 465 
 466 
Dynamic EMG data suggested that the tibialis anterior muscle remained active for a longer duration 467 
of time in DPN patients compared to HC subjects. Meta-analysis suggested that this finding was not 468 
statistically significant and demonstrated a high level of heterogeneity. Therefore, it was difficult to 469 
ascertain whether this was consistent with our hypothesis of altered muscle activity duration in DPN 470 
participants due to mis-firing and reduction in neural pathways associated with muscle recruitment 471 
and deactivation. It was also challenging to explain the shorter duration of activity of the lateral 472 
gastrocnemius muscle and longer duration of activity of the vastus lateralis muscle and the various 473 
reported findings of other muscle groups from individual studies. It seems that there are clear 474 
differences in muscle activation between DPN, DM and HC subjects; however the findings from 475 
previous studies were not consistent. It could be possible that these observations were due to changes 476 
in action potential amplitude and inconsistency in the number of motor units recruited during EMG 477 
measurement of lower limb muscle activation in DPN patients, however there is currently insufficient 478 
data to support this theory. As hypothesised, the meta-analysis results suggested that DPN participants 479 
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have higher dynamic plantar pressures at rearfoot, midfoot and forefoot sites when compared to 480 
controls. However, there were insufficient studies to carry out a meta-analysis of data collected at the 481 
hallux and lesser toe joints and the results from studies were highly contradictory. 482 
 483 
Previous reviews have highlighted gait differences in patients that have diabetes mellitus, but have not 484 
concentrated on DPN as the main focus (Wrobel and Najafi, 2010, Allet et al., 2008). The limitations 485 
of this review were the small number of included studies, the small number of participants in included 486 
studies, the high level of heterogeneity between studies, the investigation of barefoot measurements 487 
only, the exclusion of kinematic data of the foot and the language limitation to studies written in 488 
English. 489 
 490 
We can conclude from the current level of evidence that the only biomechanical factors that seems 491 
significantly different in DPN patients compared to DMC and HC groups are elevated plantar 492 
pressure and longer stance time, illustrated by moderate effect sizes from standardised mean 493 
differences. Therefore, it is probable that elevated plantar pressure coupled with a longer period of 494 
time spent in stance in DPN patients contributes to the susceptibility for skin damage through 495 
prolonged mechanical load on tissue, leading to skin break-down and ulceration (van Dieren et al., 496 
2010). Although it is possible that reduced spatiotemporal parameters, elevated vertical GRF, longer 497 
muscle duration and reduced joint kinematics contribute to foot ulceration; the current knowledge 498 
base is insufficient for firm conclusions. There were significant discrepancies between studies 499 
reporting findings. Our observations were similar to that of Allet et al and Wrobel and colleagues 500 
(Allet et al., 2008, Wrobel and Najafi, 2010). 501 
 502 
While all studies in this review utilised procedures for diagnosing DPN in participants, only two 503 
studies excluded patients with PAD. PAD has been reported to have significant effects on walking 504 
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patterns (Crowther et al., 2007, Crowther et al., 2008). The BMI of all three groups were similar and it 505 
is unlikely that this accounted for any difference in gait variables. The mean diabetes duration 506 
between DPN and DMC subjects was not significantly different in the studies included. It has been 507 
hypothesised that DPN can manifest in people with a diabetes duration greater than 10 years, as it 508 
does in those with poor glycaemic control (Oguejiofor et al., 2010, Kovac et al., 2011, Valensi et al., 509 
1997). In addition, small foot muscle atrophy resulting from the effects of hyperglycaemia and small 510 
nerve damage have also been confirmed in diabetes patients utilising MRI, before DPN becomes 511 
clinically detectable (Greenman et al., 2005). Therefore, these factors may also influence gait findings 512 
in DMC groups when compared to DPN patients. This could be a possible explanation for the similar 513 
results in DPN and DMC subjects and lack of statistical significance. However, the scope of this 514 
review was also dependent on the sample sizes of original studies, and thus, reported statistical 515 
insignificant differences may have been due to lack of power. 516 
 517 
There is paucity in biomechanical literature investigating the effects of DPN on barefoot gait 518 
parameters, particularly in relationship to the effects of severe neuropathy resulting in foot lesions and 519 
its effect on human locomotion. The clinical ramifications from this systematic review are limited due 520 
to the high level of heterogeneity and statistically insignificant results from the meta-analyses. 521 
However, it was evident that patients with DPN demonstrated greater overall dynamic plantar 522 
pressure and forefoot plantar pressure (both MPP and PTI) compared to patients without DPN. 523 
Patients with DPN also expended a longer duration of time in the stance phase. Both findings 524 
potentially contribute towards ulceration in patients with DPN. Other biomechanical findings were 525 
less clear and we therefore encourage future biomechanical studies in DPN to assess factors such as 526 
lower limb angular kinematics, kinetics and EMG and to adjust for variables such as PAD, 527 
claudication pain and history of foot ulcers in selection of participants with DPN as these factors are 528 
highly likely to influence walking patterns. 529 
 530 
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Conclusion 531 
Current evidence from the literature indicates DPN patients exhibit significantly elevated plantar 532 
pressures and occupy a longer duration of time in stance phase during gait compared to controls. We 533 
encourage future biomechanical studies in DPN to assess factors such as lower limb angular 534 
kinematics, kinetics and EMG. 535 
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